Sentence examples for deserved an additional from inspiring English sources

When asked, my father told me that all of his crew thought they deserved an additional raise after that first week.

Do you think the actions of Suárez deserve an additional penalty?

Judge Loren A. Smith of the United States Claims Court in Washington determined the award and indicated that Meritor investors might deserve an additional $402 million, but he left that question to be resolved upon appeal.

Experimental measures of decisions or choices deserve an additional comment.

Despite septic patients who develop AKI and survive their acute episode have greater likelihood for renal function recovery the negative impact of AKI on long-term mortality deserves an additional effort to closely monitor them after hospital discharge.

To Pulis's credit they were better organised and more competitive and fully deserved the additional goals scored by Joe Ledley, against his old club, and Puncheon, whose late third was a spectacular hit from 20 yards.

The borderline P values nevertheless deserved additional testing in a replication population.

"Their approach is a novel one that deserves some additional attention," says paleobotanist Norton Miller of the New York State Biological Survey in Albany.

Although these emerging biomarkers deserve additional attention, a more expanded knowledge of toxicokinetic data and information on correlations with existing biomarkers and intake doses is needed before they are adopted for use in research.

In conclusion, p53 is an important tumour suppressor gene that deserves additional investigation as a marker of therapeutic activity in CRC, and results obtained in the present study suggest that analysis of the exact status of p53 (e.g. wt or mt and functionally active or not) could be useful to predict clinical outcome after chemotherapy with TS inhibitors.

Other means for assessing treatment effects, such as a minor response (tumor shrinkage <30%%), disease control rates (a combination of objective response and stable disease), or the proportion of patients that are progression-free at landmark time points, could be considered as alternative metrics for providing early indications of an agent deserving additional clinical development.